Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

AstraZeneca, Aventis Post Strong Drug Sales. Results at Firms' Agrochemical Units Contrast

Article Abstract:

First-quarter earnings at AstraZeneca PLC and Aventis S.A. for drugs were up from last year. Agricultural chemicals sales at AstraZeneca were up 6 percent, while Aventis' agrichemical sales were down 6 percent.

Author: Moore, Stephen D.
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2000
Agricultural Chemicals, Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing, Statistics, AstraZeneca PLC, Agricultural chemicals industry, AZN

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Glaxo Wellcome's 1st-half net jumped 19% on strong sales

Article Abstract:

Glaxo Wellcome PLC posted an increase of 19% in its net income for the 2000 first-half. The company, helped by strong sales, posted 1.11 billion pounds (1.79 billion euros) for the period.

Author: Moore, Stephen D.
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2000
Glaxo Wellcome PLC

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Aventis boosts its forecast for year on strength in quarter

Article Abstract:

Aventis SA posted a 68% increase in its net income, earning 163 million euros for the 2nd quarter of 2000. The company is expecting at least a 30% increase in its earnings at the end of the year.

Author: Moore, Stephen D.
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2000

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United Kingdom, Pharmaceutical industry, Drugs, France, Aventis S.A., Finance
Similar abstracts:
  • Abstracts: AstraZeneca shares decline 7.5% despite solid results, rosy outlook. AstraZeneca shares fall 2.5% after cutting sales outlook
  • Abstracts: Auna bets on a traditionalist; Chairman Salazar wants to beat Telefonica with networks, not content. Governments Turn To `Golden Shares' To Block Deals
  • Abstracts: Progress at PetroChina? Public oil firm aims to strike out on its own. Zhenhai stands to gain from China's oil-sector reforms
  • Abstracts: Thomson Multimedia's net profit rises 70% on electronics results. Michelin's provision for restructuring deflates 1999 net
  • Abstracts: Gene Therapy Is Showing Promise As a Cancer Fighter. Aventis, Schering-Plough Launch Advanced Trials. Trials on Humans Will Begin for Drug Based on Genes. Human Genome Sciences Extends Lead Over Rivals
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.